← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Marker Therapeutics MRKR $17.8M	74	+14	+23%	$56.9M
52	GMDA 52 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	73	+17	+30%	$208M
53	53 Legend Biotech LEGN $3.72B	71	+10	+16%	$766M
54	54 Cabaletta Bio CABA $256M	68	+13	+24%	$180M
55	55 4D Molecular Therapeutics FDMT $697M	64	+12	+23%	$665M
56	56 Autolus Therapeutics AUTL $450M	63	+15	+31%	$129M
57	57 Celularity CELU $41.2M	63	-1	-2%	$238M
58	58 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	62	+6	+11%	$276M
59	LOGC 59 DELISTED LogicBio Therapeutics, Inc. Common Stock LOGC	61	+2	+3%	$128M
60	60 Pluri PLUR $12.5M	60	+14	+30%	$30.2M
61	SIOX 61 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	56	-6	-10%	$54.4M
62	62 Instil Bio TIL $42.3M	56	+56	–	$1.62B
63	DBTX 63 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	54	+54	–	$226M
64	64 Adicet Bio ACET $46.2M	53	+9	+20%	$266M
65	65 Mesoblast MESO $1.78B	52	-1	-2%	$21.9M
66	SGTX 66 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	52	+7	+16%	$439M
67	PTE 67 DELISTED PolarityTE, Inc. Common Stock PTE	50	+4	+9%	$11.9M
68	SQZ 68 DELISTED SQZ Biotechnologies Company SQZ	47	+11	+31%	$160M
69	69 Taysha Gene Therapies TSHA $1.2B	46	-5	-10%	$359M
70	70 Immatics IMTX $1.07B	44	+3	+7%	$238M
71	71 Lunai Bioworks LNAI $3.63M	41	+1	+3%	$9.6M
72	72 Imunon IMNN $5.89M	40	+15	+60%	$16.4M
73	73 DELISTED Orgenesis Inc. Common Stock ORGS	39	+2	+5%	$22.5M
74	74 Genprex GNPX $1.84M	38	+10	+36%	$35.4M
75	GRCL 75 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	36	+36	–	$321M